ASXL1 and myeloid neoplasm: In addition, we reported that ASXL1 truncation mutations enhanced BAP1 deubiquitinase (DUB) activity, and that genetically reducing BAP1 in Asxl1Y588XTg mice prevented the development of myeloid malignancies [76].